Tricuspid atresia medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 25: | Line 25: | ||
===ACC/AHA Guidelines - Recommendations for Management Strategies for the Patient with Prior Fontan Repair (DO NOT EDIT)=== | ===ACC/AHA Guidelines - Recommendations for Management Strategies for the Patient with Prior Fontan Repair (DO NOT EDIT)=== | ||
{ | |||
== | {|class="wikitable" | ||
|- | |||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.'''Management of patients with prior Fontan repair should be coordinated with a regional ACHD center. Local cardiologists, internists, and family care physicians should develop ongoing relationships with such a center with continuous availability of specialists.''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''a.'''At least yearly follow-up is recommended for patients after Fontan repair.''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''b.'''[[Arrhythmia]] management is frequently an issue, and consultation with an electrophysiologist is recommended as a vital part of care.''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''c.'''New-onset atrial tachyarrhythmia should prompt a comprehensive noninvasive imaging evaluation to identify associated atrial/baffle thrombus, anatomic abnormalities of the Fontan pathway, or ventricular dysfunction.''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki> | |||
|- | |||
|} | |||
==References== | ==References== |
Revision as of 13:40, 3 October 2012
Tricuspid atresia Microchapters |
Diagnosis |
---|
Treatment |
Special Scenarios |
Case Studies |
Tricuspid atresia medical therapy On the Web |
American Roentgen Ray Society Images of Tricuspid atresia medical therapy |
Risk calculators and risk factors for Tricuspid atresia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Keri Shafer, M.D. [2] Priyamvada Singh, MBBS [[3]]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [[4]]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Medical Therapy
ACC/AHA Guidelines - Recommendations for Medical Therapy (DO NOT EDIT)
Class I |
"1.Warfarin should be given for patients who have a documented atrial shunt, atrial thrombus, atrial arrhythmias, or a thromboembolic event.(Level of Evidence: C) " |
Class IIa |
"1.It is reasonable to treat systemic ventricle (SV) dysfunction with angiotensin-converting enzyme (ACE) inhibitors and diuretics.(Level of Evidence: C) " |
ACC/AHA Guidelines - Recommendations for Management Strategies for the Patient with Prior Fontan Repair (DO NOT EDIT)
Class I |
"1.Management of patients with prior Fontan repair should be coordinated with a regional ACHD center. Local cardiologists, internists, and family care physicians should develop ongoing relationships with such a center with continuous availability of specialists.(Level of Evidence: C) " |
"a.At least yearly follow-up is recommended for patients after Fontan repair.(Level of Evidence: C) " |
"b.Arrhythmia management is frequently an issue, and consultation with an electrophysiologist is recommended as a vital part of care.(Level of Evidence: C) " |
"c.New-onset atrial tachyarrhythmia should prompt a comprehensive noninvasive imaging evaluation to identify associated atrial/baffle thrombus, anatomic abnormalities of the Fontan pathway, or ventricular dysfunction.(Level of Evidence: C) " |